TS03 Inc Trust Units TSTIF

RE:RE:RE:Grow up and leave

[echo2]

It is my understanding that the strategic installs, for example - 2 units presently being placed in Vancouver General dedicated to duodenoscope sterilization - will be doing clinical and practical confirmation and in-the-field validation studies to show that the VP4 is effective and efficient in sterilizing the same scopes that TSO3 will be submitting next month to the FDA (though the FDA data is already done and has nothing to do with Vancouver General data, for example). The process is slow, but with 6 - 8 cycles per day, there will be a lot of data produced very quickly, over a period of 2 - 3 months, and I would hope this would be analysed and submitted for publication soon after in a reputable journal, such as the Canadian Journal of Infection Control, in which TSO3's scientists have previously published significant studies (with one in press presently). In addition, (over and above showing unofficially to regulatory bodies like the FDA that this technology really does work and replaces HLD protocols) just getting the data verifying the efficient and cost effective use of the VP4 for duodenoscopes at Vancouver General will give more ammunition to sales people at Getinge and TSO3 as they pitch their product to prospective hospitals, G I clinics, and health care providers. The hospital centres themselves don't usually put out information regarding what new techniques they are using, but they have the studies directed by a physician, scientist, or other health care provider and the studies must also be approved by an ethics committee of the health region (this latter is an essential formality). Getting all of the ducks in a row to set up a strategic install such as in Vancouver, Charleston, or New York does take a while, and this is why announcing the establishment of these strategic installs is so important, as is the data that will result from their collaboration with TSO3.

I would also like to see some kind of information from TSO3 (and Getinge) about a strategic installation or two in the European Union market.